Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04901923 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, Food Effects, and Drug-drug Interactions of ACP-196 in Healthy Participants
A Phase 1 study, sponsored by Acerta Pharma.
- Completed
- Registry status
- Phase 1
- Development phase
- 59
- Enrollment target
NCT04901923 is a Phase 1 study that has completed, run by Acerta Pharma. The registered enrollment target is 59 participants.
The verdict
NCT04901923, a Phase 1 study, has completed, sponsored by Acerta Pharma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 59 participants
- Enrollment target
Study Summary
This study is to evaluate the safety, pharmacokinetics/pharmacodynamics (PK/PD), food-effect, and drug-drug interaction study of ACP-196 in healthy participants.
Interventions
- DRUG Itraconazole
- DRUG ACP-196
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2014-03-15 |
| Est. Completion | 2014-05-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04901923
The ClinicalTrials.gov registry entry for NCT04901923 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Acerta Pharma, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Itraconazole is the first listed.
NCT04901923 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04901923 about?
NCT04901923 is a clinical study titled "A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, Food Effects, and Drug-drug Interactions of ACP-196 in Healthy Participants". This study is to evaluate the safety, pharmacokinetics/pharmacodynamics (PK/PD), food-effect, and drug-drug interaction study of ACP-196 in healthy participants.
What is the current status of trial NCT04901923?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 59 participants. The study started on 2014-03-15. Estimated completion is 2014-05-22.
What interventions are being tested in trial NCT04901923?
The interventions under investigation include: Itraconazole (DRUG), ACP-196 (DRUG).
Who is sponsoring clinical trial NCT04901923?
This trial is sponsored by Acerta Pharma, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.